Status:
UNKNOWN
Autologous Mesenchymal Stem Cell Transplantation in Liver Cirrhosis
Lead Sponsor:
Saglik Bilimleri Universitesi Gulhane Tip Fakultesi
Conditions:
Liver Cirrhosis
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
This study is aiming to investigate the efficacy of autologous mesenchymal stem cell (MSC) transplantation in 25 randomized patients with liver cirrhosis autologous mesenchymal stem cell will be deriv...
Eligibility Criteria
Inclusion
- radiological, clinical and histopathological diagnosis of liver cirrhosis
- absence of hepatocellular carcinoma or any malignancies
- no psychiatric disorder
- no serous cardiovascular and pulmonary comorbidities
- serum total bilirubin levels less than 5 mg/dL
- platelet counts more than 30.000 mm3
- more than one year follow up period after initiation of antiviral drugs
Exclusion
- alcohol intake in last one year
- initiation of antiviral medication in last one year
- systemic diseases
Key Trial Info
Start Date :
June 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2012
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT01499459
Start Date
June 1 2008
End Date
August 1 2012
Last Update
March 22 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Gulhane Military Medical Academy Department of Gastroenterology
Ankara, Turkey (Türkiye), 06018